Surgical Management Inflammatory Bowel Disease Ernesto R. Drelichman, MD, FACS St. John Health Systems
VARIETIES OF COLITIS
ULCERATIVE COLITIS AND CROHN’S DISEASE
DISTINGUISHING FEATURES OF CROHN’S DISEASE
ANATOMIC DISTRIBUTION
INFLAMMATION
OBSTRUCTION
ENDOSCOPIC APPEARANCES
ENDOSCOPIC FEATURES
COBBLESTONING
Crohn’s Stricture
FISTULIZATION
Enterovesical Fistula
PERIANAL FISTULAE AND ABSCESS
GOALS OF THERAPY
CONVENTIONAL DRUG THERAPIES
“OK, OK, you guys have had your chance – the horses want another shot at it.”
BALLOON DILATION OF CROHN’S DISEASE STRICTURES
Philosophy of Surgical Management There is no Cure for Crohn’s Disease There is no Cure for Crohn’s Disease Surgery only overcomes the complications Surgery only overcomes the complications Potential for pan-intestinal involvement Potential for pan-intestinal involvement
Surgery: Risks and Benefits Symptom relief Improved nutrition Reduced medication Surgical risk Disease recurrence Short bowel syndrome
INDICATIONS FOR SURGERY IN CROHN’S DISEASE
Crohn’s Disease Surgical Indications 75% undergo surgery 50% undergo repeat surgery Collaborative decision Collaborative decision Patient Patient Gastroenterologist Gastroenterologist Surgeon Surgeon
SURGICAL OPTIONS FOR INTRA- ABDOMINAL DISEASE IN CROHN’S DISEASE
Inflammatory Bowel Disease Disease Related Challenges Inflammatory Bowel Disease Disease Related Challenges Immunosuppression Immunosuppression Malnutrition Malnutrition fistulas fistulas abscess abscess phlegmon phlegmon thickened, shortened mesentery thickened, shortened mesentery friable tissues and vessels friable tissues and vessels Extensive disease Extensive disease
Step 5: Exteriorization, Resection, and Anastomosis
Step 4: Externalization
Step 5: Resection and Anastomosis
Crohn’s Disease Laparoscopic Colectomy - Advantages *33 patients with ileocolic Crohn’s underwent laparoscopic ileocectomy were case matched for potential confounders to an open group *33 patients with ileocolic Crohn’s underwent laparoscopic ileocectomy were case matched for potential confounders to an open group * > 60% had undergone previous surgery Young-Fadok et al. Surg Endosc 2001;450-4: Young-Fadok et al. Surg Endosc 2001;450-4: